ERGi-USU-6 mesylate

Overview

ERGi-USU-6 mesylate (Compound 7b) is an inhibitor of ERG and RIOK2 ( IC 50 values: 0.17 and 0.13 μM in VCaP cells, respectively). ERGi-USU-6 mesylate exhibits anticancer activity against ERG-positive prostate cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > RIO Kinase

Product Information

• Catalog No.: HY-139893
• CAS No.: 2756327-67-8
• Molecular Formula: C14H18N4O4S
• Molecular Weight: 338.38
• Purity: 95.0%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: 1.43 mg/mL (4.23 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source